David Oupicky, PhD

The Oupicky Lab focuses on exploring polymers and nanoparticles for delivery of drugs and nucleic acids. We are especially interested in pharmacologically active polymers (polymeric drugs) and in delivery vectors suitable for delivery of drug/gene, drug/siRNA, and drug/miRNA combinations in the treatment of metastatic cancer and inflammatory bowel disease.


  • Our new joint CPU paper on fluorinated siRNA polyplexes published in Advanced Healthcare Materials, November 2017
  • Dr. Ipek Baysal from Hacettepe University in Ankara joined the lab as a visiting faculty, October 2017
  • Johannes Bader from Ludwig-Maximilians-University of Munich joined the lab as a visiting graduate student, September 2017
  • Suthida Boonsith defended her PhD dissertation and started her faculty position at Mahidol University in Thailand. Congratulations!, August 2017
  • Prof. Oupicky appointed as a standing member of the NIH NANO study section, July 2017
  • Fei was named Presidential Graduate Fellow. Congratulations!, July 2017
  • Our new paper on chloroquine-based polycations for miRNA delivery published in Macromolecular Bioscience, July 2017
  • Our new paper on chloroquine-modified hydroxyethyl starch as an anticancer polymeric drug published in Biomacromolecules, July 2017
  • Lee’s review article on the role of CXCR4 in pancreatic cancer published in Pharmacology & Therapeutics, May 2017
  • Our new paper on mesoporous silica nanoparticles for drug delivery published in Scientific Reports, April 2017